日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer.

JNK通路抑制介导ER+乳腺癌对联合内分泌治疗和CDK4/6抑制剂的不敏感性

Alexandrou Sarah, Lee Christine S, Fernandez Kristine J, Wiharja Celine E, Eshraghi Leila, Reeves John, Reed Daniel A, Portman Neil, Phan Zoe, Milioli Heloisa H, Nikolic Iva, Cadell Antonia L, Croucher David R, Simpson Kaylene J, Lim Elgene, Hickey Theresa E, Millar Ewan K A, Alves Carla L, Ditzel Henrik J, Caldon C Elizabeth

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial

采用体外激活的外周血淋巴细胞进行过继性细胞转移疗法联合化疗治疗局部晚期或转移性三阴性乳腺癌:ImmunoBreast Ib期临床试验

Gammelgaard, Odd Lilleng; Ehmsen, Sidse; Jylling, Anne Marie Bak; Sandberg, Lene; Kirkin, Alexei F; Kodahl, Annette Raskov; Ditzel, Henrik J

Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer

单细胞测序揭示黑色素瘤和肺癌中癌/睾丸抗原表达的广泛肿瘤内异质性

Traynor, Sofie; Jakobsen, Mie K; Green, Tina M; Komic, Hana; Palarasah, Yaseelan; Pedersen, Christina B; Ditzel, Henrik J; Thoren, Fredrik B; Guldberg, Per; Gjerstorff, Morten F

Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study

针对缺乏循证治疗方案的实体瘤,开展基因组分析并扩大靶向抗癌药物的应用(PRECODE):一项前瞻性、非随机队列研究的研究方案

Hansen, Karin Holmskov; Lyng, Maria Bibi; Kodahl, Annette Raskov; Asmussen, Jon Thor; Arshad, Arman; Petersen, Henrik; Krogh, Lotte; Ehmsen, Sidse; Kristensen, Thomas Kielsgaard; Ditzel, Henrik J

Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor

针对 PI3K、ER 和 CDK4/6 的三联疗法可抑制对氟维司群和 CDK4/6 或 PI3K 抑制剂耐药的 ER 阳性乳腺癌的生长。

Karimi, Leena; Alves, Carla L; Terp, Mikkel G; Tuttolomondo, Martina; Portman, Neil; Ehmsen, Sidse; Johansen, Lene E; Bak, Martin; Lim, Elgene; Ditzel, Henrik J

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer

针对ER+乳腺癌的PI3K/AKT/mTOR通路药物治疗

Alves, Carla L; Ditzel, Henrik J

Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination

癌症患者接种第三剂mRNA COVID-19疫苗后的抗体反应以及第四剂疫苗接种的潜在时间

Ehmsen, Sidse; Asmussen, Anders; Jeppesen, Stefan S; Nilsson, Anna Christine; Østerlev, Sabina; Kragh, Amalie; Frederiksen, Henrik; Ditzel, Henrik J

Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer

癌症患者接种第四剂mRNA COVID-19疫苗后抗体滴度升高,血清阴性率降低。

Ehmsen, Sidse; Asmussen, Anders; Jeppesen, Stefan S; Nilsson, Anna Christine; Kragh, Amalie; Frederiksen, Henrik; Ditzel, Henrik J

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

出版商更正:CDK4/6 和 AKT 与内分泌疗法联合靶向可阻止 CDK4/6 抑制剂和内分泌疗法耐药性乳腺癌的进展

Alves, Carla L; Ehmsen, Sidse; Terp, Mikkel G; Portman, Neil; Tuttolomondo, Martina; Gammelgaard, Odd L; Hundebøl, Monique F; Kaminska, Kamila; Johansen, Lene E; Bak, Martin; Honeth, Gabriella; Bosch, Ana; Lim, Elgene; Ditzel, Henrik J

Deleted in malignant brain tumor 1 genetic variation confers urinary tract infection risk in children and mice

恶性脑肿瘤1缺失基因变异会增加儿童和小鼠的尿路感染风险

Hains, David S; Polley, Shamik; Liang, Dong; Saxena, Vijay; Arregui, Samuel; Ketz, John; Barr-Beare, Evan; Rawson, Ashley; Spencer, John D; Cohen, Ariel; Hansen, Pernille L; Tuttolomondo, Martina; Casella, Cinzia; Ditzel, Henrik J; Cohen, Daniel; Hollox, Edward J; Schwaderer, Andrew L